+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nicotine Replacement Therapy"

From
From
From
From
Short Acting Nicotine Replacement Therapy Market in Canada - Product Thumbnail Image

Short Acting Nicotine Replacement Therapy Market in Canada

  • Report
  • March 2026
  • 155 Pages
  • Canada
From
Short Acting Nicotine Replacement Therapy Market in China - Product Thumbnail Image

Short Acting Nicotine Replacement Therapy Market in China

  • Report
  • March 2026
  • 190 Pages
  • China
From
Short Acting Nicotine Replacement Therapy Market in India - Product Thumbnail Image

Short Acting Nicotine Replacement Therapy Market in India

  • Report
  • March 2026
  • 227 Pages
  • India
From
Short Acting Nicotine Replacement Therapy Market in Germany - Product Thumbnail Image

Short Acting Nicotine Replacement Therapy Market in Germany

  • Report
  • March 2026
  • 300 Pages
  • Germany
From
From
From
From
From
From
From
Consumer Health in the US - Product Thumbnail Image

Consumer Health in the US

  • Report
  • September 2025
  • 127 Pages
  • United States
From
Loading Indicator

The Nicotine Replacement Therapy (NRT) market is a subset of the Over the Counter (OTC) Drugs market. NRT products are designed to help people quit smoking by providing a safe and effective way to reduce nicotine cravings. These products come in a variety of forms, including patches, gum, lozenges, inhalers, and sprays. NRT products are available without a prescription and are often used in combination with other smoking cessation methods, such as counseling and support groups. NRT products are widely available in pharmacies, supermarkets, and other retail outlets. They are also available online, making them accessible to a wider range of consumers. NRT products are generally considered safe and effective, and they are often recommended by healthcare professionals as part of a comprehensive smoking cessation plan. Some companies in the NRT market include GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Perrigo. Show Less Read more